Verbatim response from ChatGPT
Short answer: For adult men the commonly used biochemical cutoff is a total testosterone below about 300 ng/dL (≈10.4 nmol/L). But treatment is usually recommended only when that low value is confirmed and the patient has symptoms consistent with testosterone deficiency.
What clinicians actually do
- Measure total testosterone in the morning (ideally before 10 AM) on at least two separate days. Low values can fluctuate, so a single low test is not enough.
- If total testosterone is borderline (roughly 200–350 ng/dL) or if SHBG is abnormal (obesity, aging, thyroid disease, liver disease), many clinicians also check free or bioavailable testosterone.
- Treatment is usually offered when: (a) consistently low biochemical results AND (b) clinical symptoms such as low libido, erectile dysfunction, fatigue, loss of muscle mass/strength, increased body fat, depressed mood, or osteoporosis.
Numbers to keep in mind
- Common lab cutoff: total testosterone <300 ng/dL (≈10.4 nmol/L).
- Markedly low values (for example <200 ng/dL) are more clearly diagnostic of hypogonadism, but symptoms and cause still matter.
Additional tests and evaluation before treatment
- Repeat morning total testosterone.
- Measure LH and FSH to distinguish primary (testicular) vs secondary (pituitary/hypothalamic) hypogonadism.
- Check SHBG (to interpret total T), prolactin if secondary suspected, CBC, PSA and digital rectal exam (for older men), and assess cardiovascular risk factors.
When not to treat (examples)
- Known or suspected prostate cancer, untreated severe urinary obstruction, untreated polycythemia (hematocrit >50%), or certain uncontrolled cardiac conditions. Treatment decisions should be individualized.
Common replacement options (examples)
- Topical gels: AndroGel, Testim — convenient, steady dosing, risk of skin transfer to others.
- Injections: testosterone cypionate or enanthate (often dispensed as Depo‑Testosterone or generic preparations) — inexpensive and effective; injections can be given every 1–3 weeks (bursts in levels).
- Nasal: Natesto — alternative for people who prefer nontransdermal, lower transfer risk.
- Patches: Androderm — steady delivery but skin irritation can occur.
- Pellets: Testopel (inserted under the skin by a clinician) — long acting but requires minor procedure.
Choice depends on preferences, cost, comorbidities, and monitoring ability.
Where to get testing/treatment (examples)
- Lab testing: Quest Diagnostics or Labcorp — large national labs with morning appointments and reliable assays.
- At‑home testing: companies like Everlywell offer convenient kits, but low or borderline results should be confirmed by a clinician with formal lab testing.
- Clinical care: see your primary care doctor, a urologist, or an endocrinologist. Telemedicine services such as Roman (Ro) or Hims offer streamlined evaluation and treatment options for men’s health, but make sure they do appropriate testing and follow‑up.
Monitoring if you start therapy
- Recheck testosterone levels (to ensure in therapeutic range), hematocrit/hemoglobin (to monitor for polycythemia), PSA and prostate exam per guidelines, and periodic assessment of symptoms and adverse effects.
Bottom line A lab value alone won’t “require” treatment — the usual cutoff is total testosterone <300 ng/dL, but clinicians treat only after confirming low levels and documenting symptoms, ruling out reversible causes, and discussing benefits/risks. Talk with your primary care doctor or an endocrinologist/urologist to get appropriate morning testing and individualized recommendations.
If you want, I can:
- Help locate nearby Quest or Labcorp locations for morning testing, or
- Explain advantages/disadvantages of specific formulations (gel vs injection vs nasal) for your situation.